Family · Pharmaceutical analytical standards
Lisdexamfetamine
A prodrug of dextroamphetamine, approved in the United States in 2007 for attention deficit hyperactivity disorder (ADHD) and in 2015, in adults, for binge eating disorder. This family brings together the active ingredient and other impurities.
Did you know?On its own it is inactive: in the blood, enzymes in red blood cells split off the amino acid L-lysine attached to the molecule and gradually release the active substance.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
